CTA
CYRX icon

Carillon Tower Advisers’s CryoPort CYRX Stock Holding History

Carillon Tower Advisers’s Portfolio CYRX Stock Details CYRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$14M Buy
+320,149
New +$15.3M 0.09% 299

Other funds holding CYRX

FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Carillon Tower Advisers's CYRX Position: Q4 2020 in Review

Carillon Tower Advisers opened a new position in CryoPort (CYRX) in Q4 2020: 320,149 shares worth $14M. The stake represents 0.09% of the portfolio and ranks #299 among its holdings.

203 funds tracked by Wall St. Rank hold CYRX as of Q4 2020.

  • Carillon Tower Advisers held 320,149 shares of CryoPort worth $14M as of Q4 2020.
  • CryoPort was a new Carillon Tower Advisers position in Q4 2020.
  • CryoPort made up 0.09% of Carillon Tower Advisers's portfolio in Q4 2020, its #299 holding.
  • 203 funds tracked by Wall St. Rank held CryoPort as of Q4 2020.

Based on Carillon Tower Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.